you are here: HomeNewsCovishield
covishield
Jump to
193 Results Found
  • COVID vaccine shortage | What if you miss second dose, will mix and match work, and other questions answered Apr 20, 2021 05:45 PM IST

    COVID vaccine shortage | What if you miss second dose, will mix and match work, and other questions answered

    Many who received the first dose in the first week of March when the vaccination drive started are supposed to take the second dose this week or in the next few days.

  • Deregulation of vaccine rollout: What it means for pharma players Apr 20, 2021 10:11 AM IST

    Deregulation of vaccine rollout: What it means for pharma players

    Dr Reddy’s, Gland Pharma, Strides, Cadila, Aurobindo are some of the names that merit a close watch as operating leverage plays out

  • Govt gives ‘advance’ of around Rs 4,500 crore to Serum Institute of India, Bharat Biotech Apr 19, 2021 09:19 PM IST

    Govt gives ‘advance’ of around Rs 4,500 crore to Serum Institute of India, Bharat Biotech

    “The Finance Ministry today has relaxed the general financial rules and permitted the Ministry of Health to pay, if they so wish, to make advance payment to vaccine suppliers, without a bank guarantee. I believe the Health Ministry is already doing so,” a top official told Moneycontrol

  • UP man gets Covaxin shot as first dose, Covishield as second Apr 19, 2021 11:44 AM IST

    UP man gets Covaxin shot as first dose, Covishield as second

    The UP CMO has ordered the suspension of the health worker till the investigation is complete.

  • EXCLUSIVE | Diverging views emerge within government on whether to provide financial help to vaccine makers Apr 16, 2021 04:17 PM IST

    EXCLUSIVE | Diverging views emerge within government on whether to provide financial help to vaccine makers

    The difference of opinion has especially widened on whether the dire situation at hand requires the government to provide direct funding to the largest vaccine maker in the world.

  • Coronavirus News Highlights: Maharashtra, Delhi clock highest single-day COVID-19 surge Apr 16, 2021 07:32 AM IST

    Coronavirus News Highlights: Maharashtra, Delhi clock highest single-day COVID-19 surge

    Coronavirus News Highlights: The cumulative number of COVID-19 vaccine doses administered in the country stands at 11,72,23,509.

  • Coronavirus News Highlights: National Eligibility cum Entrance Test-Postgraduate exam postponed Apr 15, 2021 07:43 AM IST

    Coronavirus News Highlights: National Eligibility cum Entrance Test-Postgraduate exam postponed

    Coronavirus News Highlights: Maharashtra, Chhattisgarh, Uttar Pradesh, Karnataka and Kerala cumulatively account for 68.16 percent of India's total active cases.

  • Centre to speed up vaccine approvals: List of COVID-19 jabs that may soon be available in India Apr 13, 2021 03:08 PM IST

    Centre to speed up vaccine approvals: List of COVID-19 jabs that may soon be available in India

    The government's move is likely to enable faster approval for vaccines like Johnson and Johnson, which has been approved by the WHO.

  • EXCLUSIVE | ‘Government won’t ban commercial export of Covid-19 vaccine’, sources say Apr 12, 2021 11:06 AM IST

    EXCLUSIVE | ‘Government won’t ban commercial export of Covid-19 vaccine’, sources say

    Many have argued for a ban on the commercial export of Covid-19 vaccines from India, as the second wave of the pandemic continues to infect a record number of people every day and vaccine shortages have been reported from multiple States. But the government is not keen on the proposal since both the manufacturers in India are legally obligated to fulfil contracts to supply doses to foreign buyers, and a large chunk of the global poor are dependent on India’s vaccines.

  • India to approve 5 more COVID-19 vaccines by October, Sputnik V nod likely in 10 days: Report Apr 12, 2021 10:14 AM IST

    India to approve 5 more COVID-19 vaccines by October, Sputnik V nod likely in 10 days: Report

    Novovax vaccine may be available by September, while approval for Bharat Biotech's nasal vaccine is likely by October,

  • WHO rejects Serum Institute's proposal seeking extension of Covishield's shelf life from 6 to 9 months Apr 08, 2021 08:18 PM IST

    WHO rejects Serum Institute's proposal seeking extension of Covishield's shelf life from 6 to 9 months

    The WHO has also sought a meeting with Drugs Controller General of India (DCGI) to discuss the matter, sources said.

  • EXCLUSIVE | India's global donations of jabs through 'Vaccine Maitri' on hold for a month, MEA sources say Apr 08, 2021 05:28 PM IST

    EXCLUSIVE | India's global donations of jabs through 'Vaccine Maitri' on hold for a month, MEA sources say

    India has won enormous diplomatic goodwill with free supply of vaccines to poor countries but as daily new cases continue to soar to new record, the government is facing pressure to increase domestic supply and expand the inoculation programme that is so far restricted to people who are at least 45 years old.

  • India's Serum Institute asks government for $403 million to boost AstraZeneca vaccine output Apr 07, 2021 07:19 PM IST

    India's Serum Institute asks government for $403 million to boost AstraZeneca vaccine output

    About 90 percent of the 86 million doses India has administered since mid-January have come from the Serum Institute of India, with the rest accounted for by a domestic vaccine developed by Bharat Biotech, which is also struggling to boost output.

  • 7 Deaths In UK From Blood Clots Among Millions Who Got AstraZeneca Shot Apr 03, 2021 02:58 PM IST

    7 Deaths In UK From Blood Clots Among Millions Who Got AstraZeneca Shot

    The UK’s Medicines and Healthcare products Regulatory Agency said in a statement that “out of the 30 reports up to and including March 24, sadly seven have died”.

  • COVID-19 update | India extends shelf life of AstraZeneca vaccine to 9 months Mar 30, 2021 10:40 PM IST

    COVID-19 update | India extends shelf life of AstraZeneca vaccine to 9 months

    The approval, given to a licensed version of the drug made by the Serum Institute of India (SII) and exported to dozens of countries, could help health authorities minimise vaccine wastage and better plan their inoculation programmes.

  • Covishield, Covaxin effective against UK, Brazilian variants; Work against South African strain on: Govt Mar 30, 2021 08:10 PM IST

    Covishield, Covaxin effective against UK, Brazilian variants; Work against South African strain on: Govt

    Addressing a weekly press conference of the Union health ministry, ICMR Director-General Balram Bhargava also said of 11,064 genome samples sequenced in the country, the UK variant of the virus was detected in 807, the South African variant in 47 and the Brazilian variant was found in one.

  • India changes Covishield shelf life to 9 months from the earlier 6 months: Report Mar 30, 2021 05:45 PM IST

    India changes Covishield shelf life to 9 months from the earlier 6 months: Report

    The approval, given to a licensed version of the drug made by the Serum Institute of India (SII) and exported to dozens of countries, could help health authorities minimise vaccine wastage and better plan their inoculation programmes.

  • Coronavirus News Highlights | Maharashtra accounts for 62% of total active cases in India: Health Ministry Mar 30, 2021 08:03 AM IST

    Coronavirus News Highlights | Maharashtra accounts for 62% of total active cases in India: Health Ministry

    Coronavirus News Highlights: Today is the 371st day since India implemented a nationwide lockdown to help curb the novel coronavirus pandemic.

  • COVID-19: India to focus on domestic vaccine demand; will not expand export for few months Mar 25, 2021 11:11 AM IST

    COVID-19: India to focus on domestic vaccine demand; will not expand export for few months

    So far, India has supplied 60.4 million doses of coronavirus vaccines to around 80 countries.

  • COVID-19 vaccine | No unusual bleeding, clotting reported due to Covishield: AEFI committee report Mar 23, 2021 01:30 PM IST

    COVID-19 vaccine | No unusual bleeding, clotting reported due to Covishield: AEFI committee report

    The panel undertook a deeper review of serious adverse events post-vaccination after several European countries halted the use of the AstraZeneca vaccine.

  • COVID-19 | Health centres in Chennai vaccinating everyone above 18 to avoid wastage: Report Mar 23, 2021 11:20 AM IST

    COVID-19 | Health centres in Chennai vaccinating everyone above 18 to avoid wastage: Report

    The government has so far opened up vaccination drive for frontline workers, those above 60 years and people with specified comorbidities above 45.

  • Why govt recommends increasing interval between the first and second dose of Covishield Mar 22, 2021 08:40 PM IST

    Why govt recommends increasing interval between the first and second dose of Covishield

    The Centre’s advice to increase the gap between two doses of COVID-19 vaccine from four to six weeks to six to eight weeks, pertains only to Covishield and not Covaxin.

  • Increase Covishield dose gap to 6-8 weeks, Centre tells states Mar 22, 2021 03:56 PM IST

    Increase Covishield dose gap to 6-8 weeks, Centre tells states

    This time interval between two doses has been revised only for Covishield and not Covaxin.

  • EXCLUSIVE| With 'Vaccine Maitri', India pulls off diplomatic coup against China in Africa Mar 19, 2021 03:47 PM IST

    EXCLUSIVE| With 'Vaccine Maitri', India pulls off diplomatic coup against China in Africa

    Officials say the 1.7 crore doses of vaccines from India have done in just three months, what billions of dollars in development finance deployed by China across the African continent over the past decade, haven't been able to. Gain Africa's trust.

  • COVID-19 vaccine: Several European nations to resume use of AstraZeneca shots Mar 19, 2021 09:21 AM IST

    COVID-19 vaccine: Several European nations to resume use of AstraZeneca shots

    Germany, France, Italy and other European nations have announced plans to resume using AstraZeneca's COVID-19 vaccine.

Sections